Patents by Inventor Kari Vahervuo

Kari Vahervuo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ORAL DOSAGE FORM
    Publication number: 20130274330
    Abstract: An oral dosage form of entacapone and methods for the preparation thereof are provided.
    Type: Application
    Filed: June 6, 2013
    Publication date: October 17, 2013
    Inventor: Kari VAHERVUO
  • ORAL DOSAGE FORM
    Publication number: 20120289594
    Abstract: An oral dosage form of entacapone and methods for the preparation thereof are provided.
    Type: Application
    Filed: November 11, 2011
    Publication date: November 15, 2012
    Applicant: Orion Corporation
    Inventor: Kari VAHERVUO
  • Oral Dosage Form
    Publication number: 20080187590
    Abstract: An oral dosage form of entacapone and methods for the preparation thereof are provided.
    Type: Application
    Filed: June 7, 2006
    Publication date: August 7, 2008
    Inventor: Kari Vahervuo
  • Pharmaceutical composition comprising entracapone, levodopa, and carbidopa
    Patent number: 6797732
    Abstract: An oral solid fixed dose composition comprising pharmacologically effective amounts of entacapone, levodopa, and carbidopa, or pharmaceutically acceptable salts or hydrates thereof, and comprising at least one pharmaceutically acceptable excipient. The composition can be used, e.g., for the treatment of Parkinson's disease.
    Type: Grant
    Filed: August 20, 2002
    Date of Patent: September 28, 2004
    Assignee: Orion Corporation
    Inventors: Matti Virkki, Kari Vahervuo, Marja Ritala, Marja Partanen, Mervi Niskanen, Jarmo Lintulaakso, Marja Laaksonen, Lasse Kervinen, Sari Kallioinen
  • Oral compacted composition comprising catechol derivatives
    Patent number: 6599530
    Abstract: The present invention relates to an oral compacted composition comprising entacapone, nitecapone, or a pharmaceutically acceptable salt thereof and croscarmellose sodium. The composition is premised on the discovery that croscarmellose sodium increases the release rate of entacapone or nitecapone from an oral compacted composition. Preferably the amount of croscarmellose sodium in the composition is at least 6% by weight, preferably from about 8% to about 16% by weight, especially from about 10% to about 14% by weight.
    Type: Grant
    Filed: September 14, 1998
    Date of Patent: July 29, 2003
    Assignee: Orion Corporation
    Inventor: Kari Vahervuo
  • Pharmaceutical composition comprising entracapone, levodopa, and carbidopa
    Publication number: 20030017201
    Abstract: An oral solid fixed dose composition comprising pharmacologically effective amounts of entacapone, levodopa, and carbidopa, or pharmaceutically acceptable salts or hydrates thereof, and comprising at least one pharmaceutically acceptable excipient. The composition can be used, e.g., for the treatment of Parkinson's disease.
    Type: Application
    Filed: August 20, 2002
    Publication date: January 23, 2003
    Inventors: Matti Virkki, Kari Vahervuo, Marja Ritala, Marja Partanen, Mervi Niskanen, Jarmo Lintulaakso, Marja Laaksonen, Lasse Kervinen, Sari Kallioinen
  • Pharmaceutical composition comprising entacapone, levodopa, and carbidopa
    Patent number: 6500867
    Abstract: An oral solid fixed dose composition comprising pharmacologically effective amounts of entacapone, levodopa, and carbidopa, or pharmaceutically acceptable salts or hydrates thereof, and comprising at least one pharmaceutically acceptable excipient. The composition can be used, e.g., for the treatment of Parkinson's disease.
    Type: Grant
    Filed: June 29, 2000
    Date of Patent: December 31, 2002
    Assignee: Orion Corporation
    Inventors: Matti Virkki, Kari Vahervuo, Marja Ritala, Marja Partanen, Mervi Niskanen, Jarmo Lintulaakso, Marja Laaksonen, Lasse Kervinen, Sari Kallioinen
  • NEW ORAL COMPACTED COMPOSITION COMPRISING CATECHOL DERIVATIVES
    Publication number: 20020132009
    Abstract: The present invention relates to an oral compacted composition comprising entacapone, nitecapone, or a pharmaceutically acceptable salt thereof and croscarmellose sodium. The composition is premised on the discovery that croscarmellose sodium increases the release rate of entacapone or nitecapone from an oral compacted composition. Preferably the amount of croscarmellose sodium in the composition is at least 6% by weight, preferably from about 8% to about 16% by weight, especially from about 10% to about 14% by weight.
    Type: Application
    Filed: September 14, 1998
    Publication date: September 19, 2002
    Inventor: KARI VAHERVUO
  • Composition for the oral administration of pharmaceuticals
    Patent number: 4935247
    Abstract: The invention relates to a new composition for use on a pharmaceutical granule. The composition is three-layered, comprising as the innermost layer a substantially pure fat, as the middle layer a mixture of fat and polymer, and as the outermost layer again a substantially pure fat.The composition according to the invention produces a preparation which is tasteless, especially when administered in the form of a powder or a mixture, even if the phrmaceutical to be dosed has a bad taste. Also, the preparation keeps well in mixture, and it enables a pharmaceutical to be transported past the stomach for release/absorption at the beginning of the small intestine.
    Type: Grant
    Filed: May 6, 1988
    Date of Patent: June 19, 1990
    Assignee: Orion-Yhtyma Oy
    Inventors: Esko Marttila, Ilkka Larma, Kari Vahervuo, Jaakko Uotila